[CHAPERONES FUNCTION HSP60 AND HSP90 AND THEIR ROLE IN CARDIAC PATHOLOGY]

Likars'Ka Sprava
|October 24, 2015
PubMed

Insights

Chaperones are key proteins involved in cellular functions and disease development. This review explores their role in atherosclerosis, coronary heart disease, and inflammatory processes.

Area of Science:

  • Molecular Biology
  • Immunology
  • Pathology

Context:

  • Chaperones are essential proteins that assist in protein folding and cellular homeostasis.
  • Dysfunctional chaperones are implicated in various pathological conditions.

Purpose:

  • To review the multifaceted roles of chaperones in the human body.
  • To elucidate the involvement of chaperones in the pathogenesis of atherosclerosis and coronary heart disease.
  • To explore the intricate communication networks between chaperones and the immune and endocrine systems, as well as inflammatory pathways.

Summary:

  • This review details the fundamental functions of chaperones within the cellular environment.
  • It highlights the critical involvement of chaperones in the progression of atherosclerosis and coronary heart disease.
  • The review also emphasizes the significant interactions between chaperones and the immune and endocrine systems, modulating inflammatory responses.

Impact:

  • Provides a comprehensive understanding of chaperone biology in health and disease.
  • Offers insights into potential therapeutic targets for cardiovascular diseases and inflammatory conditions.
  • Underscores the interconnectedness of cellular protein quality control with systemic physiological processes.

Related Concept Videos

Molecular Chaperones and Protein Folding03:00

Molecular Chaperones and Protein Folding

The native conformation of a protein is formed by interactions between the side chains of its constituent amino acids. When the amino acids cannot form these interactions, the protein cannot fold by itself and needs chaperones. Notably, chaperones do not relay any additional information required for the folding of polypeptides; the native conformation of a protein is determined solely by its amino acid sequence. Chaperones catalyze protein folding without being a part of the folded protein.
The...
20.8K
Molecular Chaperones and Protein Folding03:00

Molecular Chaperones and Protein Folding

15.6K
Bacterial Protein Maturation01:26

Bacterial Protein Maturation

Bacterial protein maturation is a tightly regulated process that ensures newly synthesized polypeptides achieve correct functional conformations. This maturation involves a series of modifications, folding events, and quality control steps, often assisted by specialized chaperone proteins.N-Terminal ModificationsThe maturation of bacterial polypeptides begins cotranslationally as the polypeptide exits the ribosome. The first amino acid, N-formylmethionine (fMet), is typically modified at the...
702
Post-translational Translocation of Proteins to the RER01:27

Post-translational Translocation of Proteins to the RER

A sizable fraction of proteins destined for ER are first synthesized in the cell cytosol and then transported across the ER membrane–a process called post-translational translocation. Similar to cotranslationally translocated proteins, these proteins also use the Sec translocon complex to enter the ER lumen.
Targeting proteins to the ER
Hsp40 and Hsp70 chaperone molecules bind the translated proteins in the cytosol to prevent their folding. The chaperone binding helps to keep the signal...
8.1K
Export of Misfolded Proteins out of the ER01:32

Export of Misfolded Proteins out of the ER

After folding, the ER assesses the quality of secretory and membrane proteins. The correctly folded proteins are cleared by the calnexin cycle for transport to their final destination, while misfolded proteins are held back in the ER lumen. The ER chaperones attempt to unfold and refold the misfolded proteins but sometimes fail to achieve the correct native conformation. Such terminally misfolded proteins are then exported to the cytosol by ER-associated degradation or ERAD pathway for...
5.6K
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
718